Generic Drug Deal Lowers Cost Of AIDS Medication
Posted on: Friday, 17 April 2009, 10:30 CDT
A group of generic drug manufacturers has arranged a bulk purchase to help the cost of AIDS medicines in poor countries come down further in price, Reuters reported.
The deal will provide steeper discounts on a range of life-saving treatments.
The Clinton Foundation HIV/AIDS Initiative and the international drug-purchasing consortium Unitaid announced the agreement on Friday.
The most affordable generic second-line drug regimen falls to $590 annually from more than $700 a year ago. These types of drugs are needed when patients develop resistance to initial treatment.
Now dropping 30 percent from 2008 is a one-pill, once-daily first-line regimen based on the drug tenofovir that is now available for $210 a year.
The group said the new price agreement would benefit 41 adult and pediatric formulations at an average reduction of 16 percent compared to 2008.
While the human immunodeficiency virus (HIV) that causes AIDS currently has no cure, doctors can prescribe combinations of drugs that can keep the virus from replicating and damaging the immune system.
Experts say around 33 million people around the world are infected with the AIDS virus, with the majority being in Africa and other developing countries.
---
On the Net:
Source: redOrbit Staff & Wire Reports
Related Articles
- Promising New HIV-AIDS Drug, 1st in New Class, Approved for Canadian Market
- Hepatitis B Drug Triggers HIV Resistance
- AIDS Drugs Still Effective After 10 Years
- Promising AIDS Drugs-Combination Study Expanded
- Disappointing Results Cancel AIDS Drug Therapy Study
- AIDS Drug From Durham, N.C.-Based Drug Maker, Roche Shows Promise
- Rare Drug-Resistant HIV Found in NYC
- Rare Drug-Resistant HIV Found in N.Y.
- Docs Worry AIDS Drug Use May Be Halted
- Many Now Worry AIDS Drug Will Be Halted
 |
 |
User Comments (0)
RSS Feeds